Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Auditor change
89bio, Inc. (ETNB) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/21/2023 4 Mansbach Harry H (Chief Medical Officer) has filed a Form 4 on 89bio, Inc.
Txns: Paid exercise price by delivering 577 shares @ $15.64, valued at $9k
Paid exercise price by delivering 1,014 shares @ $15.46, valued at $15.7k
08/21/2023 4 PALEKAR ROHAN (CEO) has filed a Form 4 on 89bio, Inc.
Txns: Paid exercise price by delivering 4,501 shares @ $15.46, valued at $69.6k
08/21/2023 4 Martins Ryan (CFO) has filed a Form 4 on 89bio, Inc.
Txns: Paid exercise price by delivering 346 shares @ $15.64, valued at $5.4k
Paid exercise price by delivering 753 shares @ $15.46, valued at $11.6k
08/21/2023 4 Le-Nguyen Quoc (See Remarks) has filed a Form 4 on 89bio, Inc.
Txns: Paid exercise price by delivering 577 shares @ $15.64, valued at $9k
Paid exercise price by delivering 1,014 shares @ $15.46, valued at $15.7k
07/18/2023 4 LAPORTE KATHLEEN (Director) has filed a Form 4 on 89bio, Inc.
Txns: Sold 12,500 shares @ $18.8, valued at $235k
Exercised 12,500 options to buy @ $2.64, valued at $33k
07/05/2023 4 Mansbach Harry H (Chief Medical Officer) has filed a Form 4 on 89bio, Inc.
Txns: Granted 8,334 shares @ $0
Paid exercise price by delivering 2,882 shares @ $18.95, valued at $54.6k
07/05/2023 4 Le-Nguyen Quoc (See Remarks) has filed a Form 4 on 89bio, Inc.
Txns: Granted 8,334 shares @ $0
Paid exercise price by delivering 2,882 shares @ $18.95, valued at $54.6k
07/05/2023 4 PALEKAR ROHAN (CEO) has filed a Form 4 on 89bio, Inc.
Txns: Granted 33,334 shares @ $0
Paid exercise price by delivering 16,527 shares @ $18.95, valued at $313.2k
07/05/2023 4 Martins Ryan (CFO) has filed a Form 4 on 89bio, Inc.
Txns: Granted 5,834 shares @ $0
Paid exercise price by delivering 2,018 shares @ $18.95, valued at $38.2k
06/07/2023 4 PALEKAR ROHAN (CEO) has filed a Form 4 on 89bio, Inc.
Txns: Sold 15,000 shares @ $20, valued at $300k
Exercised 15,000 options to buy @ $1.93, valued at $29k
06/05/2023 4 Atkinson Edward Morrow III (Director) has filed a Form 4 on 89bio, Inc.
Txns: Sold 6,250 shares @ $17.91, valued at $111.9k
Exercised 6,250 options to buy @ $2.61, valued at $16.3k
05/11/2023 4 Le-Nguyen Quoc (See Remarks) has filed a Form 4 on 89bio, Inc.
Txns: Sold 13,683 shares @ $18.11, valued at $247.8k
Exercised 60,945 options to buy @ $3.11, valued at $189.5k
Exercised 18,626 options to buy @ $3.11, valued at $57.9k
04/06/2023 4 Martins Ryan (CFO) has filed a Form 4 on 89bio, Inc.
Txns: Sold 8,721 shares @ $14.95, valued at $130.4k
04/04/2023 4 Martins Ryan (CFO) has filed a Form 4 on 89bio, Inc.
Txns: Granted 5,833 shares @ $0
Paid exercise price by delivering 2,018 shares @ $15.23, valued at $30.7k
Granted 7,500 shares @ $0
Paid exercise price by delivering 2,594 shares @ $15.23, valued at $39.5k
04/04/2023 4 PALEKAR ROHAN (CEO) has filed a Form 4 on 89bio, Inc.
Txns: Granted 33,333 shares @ $0
Paid exercise price by delivering 15,443 shares @ $15.23, valued at $235.2k
04/04/2023 4 Mansbach Harry H (Chief Medical Officer) has filed a Form 4 on 89bio, Inc.
Txns: Granted 8,333 shares @ $0
Paid exercise price by delivering 2,882 shares @ $15.23, valued at $43.9k
04/04/2023 4 Le-Nguyen Quoc (See Remarks) has filed a Form 4 on 89bio, Inc.
Txns: Granted 8,333 shares @ $0
Paid exercise price by delivering 2,882 shares @ $15.23, valued at $43.9k
Granted 3,750 shares @ $0
Paid exercise price by delivering 1,297 shares @ $15.23, valued at $19.8k
03/27/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/27/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/22/2023 4 Mansbach Harry H (Chief Medical Officer) has filed a Form 4 on 89bio, Inc.
Txns: Paid exercise price by delivering 2,127 shares @ $13.97, valued at $29.7k
02/22/2023 4 Martins Ryan (CFO) has filed a Form 4 on 89bio, Inc.
Txns: Paid exercise price by delivering 1,750 shares @ $13.97, valued at $24.4k
Sold 2,540 shares @ $13.89, valued at $35.3k
02/22/2023 4 Le-Nguyen Quoc (See Remarks) has filed a Form 4 on 89bio, Inc.
Txns: Paid exercise price by delivering 2,140 shares @ $13.97, valued at $29.9k
02/22/2023 4 PALEKAR ROHAN (CEO) has filed a Form 4 on 89bio, Inc.
Txns: Paid exercise price by delivering 6,279 shares @ $13.97, valued at $87.7k
02/13/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/13/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/13/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/13/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/13/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/13/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/13/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/13/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/13/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/13/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/13/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy